P2y12 Inhibitors - Pharma

Relevant Publications

Impact of P2Y12 inhibitors on clinical outcomes in sepsis-3 patients receiving aspirin: a propensity score matched analysis.

Issue Release: 2024

Effects of Proton Pump Inhibitors on Cardiovascular Events and Inflammatory Factors in Patients With Upper Gastrointestinal Bleeding Undergoing Dual Antiplatelet Therapy.

Issue Release: 2024

Cardiorespiratory Fitness Is Associated with Decreased Platelet Reactivity.

Issue Release: 2024

Comparison of Heart Rates in Patients Initiated on Ticagrelor Versus Other P2Y12 Inhibitors After an Inferior ST Elevation Myocardial Infarction (STEMI).

Issue Release: 2024

Racial differences in P2Y12 inhibitor responsiveness in patients undergoing neuro-endovascular procedures: A cohort from the Middle East.

Issue Release: 2024

Optimal antithrombotic strategy following valve-in-valve transcatheter aortic and mitral valve replacement.

Issue Release: 2024

Does morphine attenuate the Inhibition of Platelet Aggregation for both oral and parenteral P2Y12 inhibitors?

Issue Release: 2024

Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation.

Issue Release: 2024

ADP-mediated Modulation of Intracellular Calcium Responses in Chromaffin Cells: The Role of Ectonucleoside Triphosphate Diphosphohydrolase 2 on Rat Adrenal Medulla Function.

Issue Release: 2024

Incidence, Predictors, and Outcomes of Clinically Significant Post-ERCP Bleeding: a Contemporary Multi-center Study.

Issue Release: 2024

Platelet inhibitor withdrawal and outcomes after coronary artery surgery: an individual patient data meta-analysis.

Issue Release: 2024

Women Experience Higher Rates of Mortality Following Thoracic Endovascular Aneurysm Repair.

Issue Release: 2024

Safety and efficacy of cangrelor in endovascular thrombectomy compared with glycoprotein IIb/IIIa Inhibitors.

Issue Release: 2024

The Balancing Act: A Rational Approach to Postintervention Dual Antiplatelet Therapy.

Issue Release: 2024

Cost-effectiveness of Implementing a Genotype-Guided De-Escalation Strategy in Patients with Acute Coronary Syndrome.

Issue Release: 2024

Treatment and outcomes of patients with chronic lung disease and acute myocardial infarction: Insights from the nationwide AMIS plus registry.

Issue Release: 2024

Temporal trends in characteristics and outcomes after myocardial infarction in patients with and without peripheral artery disease - A Nationwide, register-based follow-up study.

Issue Release: 2024

The impact of frailty on initiation, continuation and discontinuation of secondary prevention medications following myocardial infarction.

Issue Release: 2024

Evaluation of pharmacist-led transition of care program in patients with acute coronary syndrome.

Issue Release: 2024

P2Y12 inhibitor use predicts hematoma expansion in patients with intracerebral hemorrhage.

Issue Release: 2024

How Can Technology Aid in Patient Education?

What is Generic Competition?

What Strategies do Brand-Name Companies Use to Delay Generic Entry?

What are Adverse Drug Events?

What Challenges Exist in Patient Education?

Who are Pharmacists?

How Can ADEs be Prevented?

What Are the Therapeutic Approaches to Mitigate Cellular Stress?

What are the Challenges in Implementing Collaborative Care Models?

Why is Geriatric Care Important?

Partnered Content Networks

Relevant Topics